左心室辅助装置植入时合并心房颤动患者的生存与不良事件:欧洲机械循环支持患者登记分析
本研究基于欧洲机械循环支持患者登记,纳入1821例连续流左心室辅助装置患者,比较术前心房颤动(421例,23.1%)与窦性心律(1400例,76.9%)患者的生存和不良事件。术前心房颤动患者≤90天和4年生存率低于窦性心律患者,但倾向性评分匹配后生存差异仅为趋势,多变量分析中心房颤动不再是死亡预测因子;24个月时术前心房颤动患者脑血管意外发生率更高。
要点
- 术前心房颤动患者≤90天生存率81.9% vs 窦性心律87.1%(P=0.0047),4年生存率35.4% vs 44.2%(P=0.0083)。
- 倾向性评分匹配后生存差异仅为趋势(P=0.087),多变量分析中心房颤动不再是死亡预测因子。
- 24个月时术前心房颤动患者脑血管意外发生率77% vs 窦性心律94.3%(P<0.0001)。
核心结论
- 术前心房颤动的左心室辅助装置植入患者生存更差,但多变量分析和倾向性评分匹配后心房颤动不再显著,提示这些患者术前状况更差。
- 仅有术前心房颤动且存活超过24个月的患者脑血管意外风险更高。
研究设计与样本
- 基于欧洲机械循环支持患者登记的分析,纳入连续流左心室辅助装置、心房颤动或窦性心律且有随访的患者。
- 共纳入1821例患者(83%男性),中位年龄57岁,中位随访13.1个月(四分位距4.3-27.7)。
- 术前心电图节律为心房颤动421例(23.1%),窦性心律1400例(76.9%)。
- 采用Kaplan-Meier分析生存、无脑血管意外、泵血栓、出血及泵血栓/脑血管意外复合终点,并行倾向性评分匹配后的Kaplan-Meier分析和Cox回归分析生存预测因素。
主要发现
- 术前心房颤动患者≤90天生存率81.9% vs 窦性心律87.1%(P=0.0047),4年生存率35.4% vs 44.2%(P=0.0083)。
- 倾向性评分匹配后Kaplan-Meier分析显示生存差异仅为趋势(P=0.087)。
- 单变量分析证实术前心房颤动是死亡预测因子,但多变量分析未证实。
- 不良事件发生率无差异。
- 24个月时术前心房颤动患者脑血管意外发生率77% vs 窦性心律94.3%(P<0.0001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Atrial fibrillation (AF) is a risk factor for mortality and cerebrovascular accidents (CVAs) and is common in patients with heart failure. This study evaluated survival and adverse events in patients with a left ventricular assist device (LVAD) and a history of AF in the European Registry for Patients with Mechanical Circulatory Support. METHODS: Patients with a continuous-flow LVAD, AF or sinus rhythm (SR) and a follow-up were included. Kaplan-Meier analyses for survival (including a propensity-scored matched analysis), freedom from CVA, pump thrombosis, bleeding and a composite of pump thrombosis/CVA were performed. To correct for covariate imbalance, a Kaplan-Meier (KM) analysis was performed after propensity score (PS) matching the groups. Finally, a Cox regression was performed for predictors of lower survival. RESULTS: Overall, 1821 patients (83% male) were included, with a median age of 57 years and a median follow-up of 13.1 months (interquartile range: 4.3-27.7). Preoperative Electrocardiogram (ECG) rhythm was AF in 421 (23.1%) and SR in 1400 (76.9%) patients. Patients with pre-LVAD AF had a lower ≤90-day (81.9% vs 87.1%, P = 0.0047) and 4-year (35.4% vs 44.2%, P = 0.0083) survival compared to SR. KM analysis with PS matching groups revealed a trend (P = 0.087) towards decreased survival. Univariable analyses confirmed pre-LVAD AF as a predictor for mortality, but the multivariable analysis did not. No difference in the rate of adverse events was found. An analysis of patients at 24 months revealed a higher rate of CVAs for pre-LVAD AF patients (77% vs 94.3%, P < 0.0001). CONCLUSIONS: Patients with pre-LVAD AF undergoing LVAD implantation had a worse survival. However, after performing a multivariate analysis, and PS matching analysis, AF was no longer significant, indicating a worser preoperative condition in these patients. Concerning thrombo-embolic events, only patients with pre-LVAD AF alive beyond 24 months have a higher risk of CVAs.
引用
- Antonides CFJ, Yalcin YC, Veen KM, et al. Survival and adverse events in patients with atrial fibrillation at left ventricular assist device implantation: an analysis of the European Registry for Patients with Mechanical Circulatory Support. Eur J Cardiothorac Surg. 2022. PMID: 35076057. doi:10.1093/ejcts/ezac023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。